Radionuclide Therapy of HER2-Expressing Human Xenografts Using Affibody-Based Peptide Nucleic Acid-Mediated Pretargeting: In Vivo Proof of Principle

K Westerlund, M Altai, B Mitran, Mark Konijnenberg, M Oroujeni, C Atterby, Marion Jong, A Orlova, J Mattsson, P Micke, AE Karlstrom, V Tolmachev

Research output: Contribution to journalArticleAcademicpeer-review

44 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1092-1098
Number of pages7
JournalJournal of Nuclear Medicine
Issue number7
Publication statusPublished - 2018

Research programs

  • EMC MM-01-40-01
  • EMC NIHES-03-30-02

Cite this